Dec 18, 2018· Comment from Association for Accessible Medicines (AAM)· FDA-2016-D-2268-0686
The Association for Accessible Medicines (AAM) is pleased to provide comments on the Food and Drug Administrations (FDAs or the Agencys) revised draft Guidance for Industry, Insanitary Conditions at Compounding Facilities.